-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelpForm.pdf
August 01, 2012 - NCINQ Measure Submission: Tobacco Use and Help with Quitting Among Adolescents
Attachment A: CHIPRA Pediatric Quality Measures Program (PQMP) Candidate
Measure Submission Form (CPCF)
Italics indicate instructions for how to complete a specific field. << >> indicates the name of a text field in the
online version o…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-fullreport.pdf
May 01, 2018 - Use of Multiple Concurrent Antipsychotics in Children
1
Use of Multiple Concurrent Antipsychotics in Children
Section 1. Basic Measure Information
1.A. Measure Name
Use of Multiple Concurrent Antipsychotics in Children
1.B. Measure Number
0126
1.C. Measure Description
Please provide a non-technical descript…
-
www.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/references.html
July 01, 2021 - Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit
References
Previous Page
Table of Contents
Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit
Introduction
Overview
About the Measure
Key Driver Diagrams
Quality I…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-147-fullreport.pdf
February 01, 2019 - Follow-Up Visit for Children and Adolescents on Antipsychotics
1
Follow-up Visit for Children and Adolescents on
Antipsychotics
Section 1. Basic Measure Information
1.A. Measure Name
Follow-up Visit for Children and Adolescents on Antipsychotics
1.B. Measure Number
0147
1.C. Measure Description
Please provi…
-
www.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/qi-strategies.html
July 01, 2021 - Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit
Quality Improvement Strategies
Previous Page Next Page
Table of Contents
Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit
Introduction
Overview
About the Measure
Key…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-testing-summary.pdf
February 22, 2019 - Measures To Assess the Safe and Judicious Use of Antipsychotics in Children and Adolescents Field Test Summary
1
National Collaborative for Innovation in Quality Measurement (NCINQ)
Measures to Assess the
Safe and Judicious Use of Antipsychotics in Children and Adolescents
Field Test Summary
This report sum…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-147-antipsychotics-testing-summary.pdf
February 22, 2019 - CHIPRA 147: Antipsychotics Testing Summary
1
National Collaborative for Innovation in Quality Measurement (NCINQ)
Measures to Assess the
Safe and Judicious Use of Antipsychotics in Children and Adolescents
Field Test Summary
This report summarizes testing results across seven measures developed to evaluate …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-149-testing-summary.pdf
February 22, 2019 - CHIPRA 149: Antipsychotics Testing Summary
1
National Collaborative for Innovation in Quality Measurement (NCINQ)
Measures to Assess the
Safe and Judicious Use of Antipsychotics in Children and Adolescents
Field Test Summary
This report summarizes testing results across seven measures developed to evaluate …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-149-appendix-1-tables-1-5.pdf
October 22, 2013 - CHIPRA 149: Appendix 1, Tables 1 to 5
Appendix 1. Guidelines and Measure-Specific Testing Results
Metabolic Screening for Children and Adolescents Newly on Antipsychotics
Guidelines for Metabolic Screening and Monitoring in Children and Adolescents on Antipsychotics
Organization (Date) Recommendation Type/Grade
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-section-5-appendix-1-tables-1-5.pdf
October 22, 2013 - Section 5, Appendix 1, Tables 1-5
Appendix 1. Guidelines and Measure-Specific Testing Results
Metabolic Monitoring for Children and Adolescents on Antipsychotics
…
-
www.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/about.html
September 01, 2021 - Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit
About the Measure
Previous Page Next Page
Table of Contents
Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit
Introduction
Overview
About the Measure
Key Driver Diagr…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-section-5-appendix-1.pdf
October 12, 2013 - CHIPRA 148: Section 5, Appendix 1
Appendix 1. Guidelines and Measure-Specific Testing Results
Use of First-Line Psychosocial Care in Children and Adolescents on Antipsychotics
Guidelines Supporting Use of Psychosocial Interventions for Children and Adolescents on Antipsychotics
Guideline (Date) Population Recomm…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p012-ef.pdf
January 01, 2015 - Measure: Adolescent Assessment of Preparation for Transition (ADAPT) to Adult-Focused Health Care
Measure: Adolescent Assessment
of Preparation for Transition (ADAPT)
to Adult-Focused Health Care
Measure Developer: Center of Excellence for Pediatric Quality Measurement (CEPQM)
Numerator Denominator Exclusions …
-
www.ahrq.gov/policymakers/chipra/demoeval/what-we-learned/co-nm-specialinnovation.html
August 01, 2015 - Electronic Student Health Questionnaire (eSHQ) enhances risk assessment for adolescents
Special Innovation Feature
August 2015
Contents
Summary
Problems Addressed
What the Staff Did
Did It Work?
Adoption Considerations
Endnotes
Learn More
For More Information
Summary
The electronic S…
-
www.ahrq.gov/research/findings/studies/index.html?page=291
January 01, 2024 - AHRQ Research Studies
Sign up: AHRQ Research Studies Email updates
Research Studies is a compilation of published research articles funded by AHRQ or authored by AHRQ researchers.
Results 7276 to 7300 of 12214 Research Studies Displayed
Pagination
« first
« First
‹ previous
‹‹
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-147-appendix-1-tables-1-3.pdf
October 22, 2013 - CHIPRA 147: Appendix 1, Tables 1 to 3
Appendix 1. Guidelines and Measure-Specific Testing Results
Follow-Up Visit for Children and Adolescents on Antipsychotics
Guidelines Supporting Follow-Up Visits for Children and Adolescents on Antipsychotics
Organization (Year) Population Recommendation Grade*
American Aca…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
March 01, 2015 - Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents
Measures: Safe and Judicious Antipsychotic
Use in Children and Adolescents
Measure Developer: National Collaborative for Innovation in Quality Measurement
As part of the Pediatric Quality Measures Program (PQMP), the Agency for Healthcare R…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-246-fullreport.pdf
December 01, 2019 - Depression Screening and Follow-up for Adolescents and Adults
1
Depression Screening and Follow-up for Adolescents
and Adults
Section 1. Basic Measure Information
1.A. Measure Name
Depression Screening and Follow-up for Adolescents and Adults (Health Plan)
1.B. Measure Number
0246
1.C. Measure Description
P…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/demoeval/what-we-learned/co-nm-specialinnovation.pdf
January 01, 2020 - Electronic Student Health Questionnaire (eSHQ) enhances risk assessment for adolescents: Special Innovation Feature, August 2015
Page 1
The National Evaluation of the
CHIPRA Quality Demonstration Grant Program
SUMMARY
The electronic Student Health Questionnaire (eSHQ)
improved early identification of health ris…
-
www.ahrq.gov/patient-safety/settings/ambulatory/diagnostic-safety/toolkit.html
November 01, 2018 - Reducing Diagnostic Errors in Primary Care Pediatrics Toolkit
The Reducing Diagnostic Errors in Primary Care Pediatrics Toolkit aims to assist primary care practice teams with a systematic approach to reduce diagnostic errors among children in three important areas:
Elevated blood pressure, which is misdi…